Limited influence of germline genetic variation on all-cause mortality in women with early onset breast cancer: evidence from gene-based tests, single-marker regression, and whole-genome prediction

scientific article published on 13 May 2017

Limited influence of germline genetic variation on all-cause mortality in women with early onset breast cancer: evidence from gene-based tests, single-marker regression, and whole-genome prediction is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1085406785
P356DOI10.1007/S10549-017-4287-4
P2888exact matchhttps://scigraph.springernature.com/pub.10.1007/s10549-017-4287-4
P932PMC publication ID5510603
P698PubMed publication ID28503721

P50authorJenny Chang-ClaudeQ21263057
Muhammad G KibriyaQ56125220
John HopperQ56726496
Esther M. JohnQ59752419
Irene L AndrulisQ64516140
Habibul AhsanQ71040112
Maria ArgosQ71040248
Mary Beth TerryQ75067963
Molly Scannell BryanQ85667683
Dezheng HuoQ89094846
Mary B. DalyQ96105692
Jeanine M GenkingerQ100394514
Marilie GammonQ104751082
Saundra S. BuysQ109562977
Kathleen E. MaloneQ110376035
Farzana JasmineQ114337547
Olofunmilayo I OlopadeQ114435377
P2093author name stringLin Chen
P2860cites workPotential etiologic and functional implications of genome-wide association loci for human diseases and traitsQ22066284
A global reference for human genetic variationQ25909434
An Integrated Genome-Wide Systems Genetics Screen for Breast Cancer Metastasis Susceptibility GenesQ27308942
Improvement in risk prediction, early detection and prevention of breast cancer in the NHS Breast Screening Programme and family history clinics: a dual cohort studyQ28075560
Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic AssociationsQ28388475
The GenABEL Project for statistical genomicsQ28600877
A genome-wide association study identifies locus at 10q22 associated with clinical outcomes of adjuvant tamoxifen therapy for breast cancer patients in JapaneseQ28943542
Large-scale genotyping identifies 41 new loci associated with breast cancer riskQ29416989
A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age.Q29417036
GCTA: a tool for genome-wide complex trait analysisQ29547216
GenABEL: an R library for genome-wide association analysisQ29614587
A general framework for estimating the relative pathogenicity of human genetic variantsQ29615730
TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancerQ33566957
Poly-omic prediction of complex traits: OmicKrigingQ33812687
Application status of tamoxifen in endocrine therapy for early breast cancerQ35758139
Breast Cancer Mortality in African-American and Non-Hispanic White Women by Molecular Subtype and Stage at Diagnosis: A Population-Based StudyQ35815602
Is breast cancer prognosis inherited?Q35906350
Optimal unified approach for rare-variant association testing with application to small-sample case-control whole-exome sequencing studiesQ36152947
Genomic variant annotation and prioritization with ANNOVAR and wANNOVAR.Q36479375
Prediction of breast cancer risk based on profiling with common genetic variantsQ36583004
Underlying causes of the black-white racial disparity in breast cancer mortality: a population-based analysisQ37261038
Personalizing breast cancer staging by the inclusion of ER, PR, and HER2.Q38168732
Personalized therapy for breast cancerQ38196466
Pharmacogenomics toward personalized tamoxifen therapy for breast cancerQ38364888
Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association studyQ39006292
Cancer Statistics, 2017.Q39038674
Breast Cancer Risk From Modifiable and Nonmodifiable Risk Factors Among White Women in the United StatesQ39734134
Breast cancer statistics, 2015: Convergence of incidence rates between black and white womenQ40379855
Survival time according to the year of recurrence and subtype in recurrent breast cancerQ41650346
Factors used to select adjuvant therapy of breast cancer in the United States: an overview of age, race, and socioeconomic status.Q43843528
Progesterone Receptor Status Significantly Improves Outcome Prediction Over Estrogen Receptor Status Alone for Adjuvant Endocrine Therapy in Two Large Breast Cancer DatabasesQ44438551
Long-term outcome prediction by clinicopathological risk classification algorithms in node-negative breast cancer--comparison between Adjuvant!, St Gallen, and a novel risk algorithm used in the prospective randomized Node-Negative-Breast Cancer-3 (Q46340590
Familial concordance in cancer survival: a Swedish population-based studyQ47573086
One step at a time: CYP2D6 guided tamoxifen treatment awaits convincing evidence of clinical validity.Q53088506
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectwhole genome sequencingQ2068526
genetic variationQ349856
P304page(s)707-717
P577publication date2017-05-13
P1433published inBreast Cancer Research and TreatmentQ326085
P1476titleLimited influence of germline genetic variation on all-cause mortality in women with early onset breast cancer: evidence from gene-based tests, single-marker regression, and whole-genome prediction
P478volume164

Reverse relations

cites work (P2860)
Q59756250Germline Variation and Breast Cancer Incidence: A Gene-Based Association Study and Whole-Genome Prediction of Early-Onset Breast Cancer
Q90273794Mutational landscape differences between young-onset and older-onset breast cancer patients

Search more.